GetTopicDetailResponse(id=ca34223639f, topicName=中等收入國家, introduction=中等收入國家, content=null, image=null, comments=0, allHits=782, url=https://h5.medsci.cn/topic?id=22363, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=40086, tagList=[TagDto(tagId=40086, tagName=中等收入國家)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2233615, encodeId=2f412233615f8, content=<a href='/topic/show?id=ca34223639f' target=_blank style='color:#2F92EE;'>#中等收入國家#</a> <a href='/topic/show?id=f5e81190998d' target=_blank style='color:#2F92EE;'>#allo-HCT#</a>, objectTitle=Front Immunol：門診allo-HCT+降低強度預處理方案治療ALL或AML的低收入中等收入國家患者的療效研究, objectType=article, longId=848877, objectId=32d98488e79f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721281386020_92910.jpg, objectUrl=/article/show_article.do?id=32d98488e79f, replyNumber=0, likeNumber=47, createdTime=2024-10-28, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=32d98488e79f, moduleTitle=Front Immunol：門診allo-HCT+降低強度預處理方案治療ALL或AML的低收入中等收入國家患者的療效研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=32d98488e79f)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
